Nephros, Inc. (NEPH)

Nephros Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	23	36	12	60	85	79
Market Cap Growth	106.31%	203.88%	-80.23%	-28.67%	6.82%	-
Enterprise Value	20	34	9	54	79	78
PE Ratio	-	-23.03	-1.62	-14.70	-17.76	-23.17
PS Ratio	1.58	2.55	1.20	5.91	9.89	7.67
PB Ratio	2.72	4.34	2.13	5.16	6.76	16.95
P/FCF Ratio	-117.81	48.24	-3.54	-41.55	-11.85	-34.60
P/OCF Ratio	-190.83	43.87	-3.69	-42.61	-12.26	-34.81
EV/Sales Ratio	1.45	2.37	0.94	5.32	9.18	7.51
EV/EBITDA Ratio	-17.06	-24.88	-1.34	-14.26	-17.66	-23.88
EV/EBIT Ratio	-14.74	-21.49	-1.28	-13.38	-16.87	-22.50
EV/FCF Ratio	-107.99	44.96	-2.79	-37.44	-11.00	-33.89
Debt / Equity Ratio	0.21	0.22	0.20	0.09	0.17	0.54
Debt / EBITDA Ratio	-1.38	-1.35	-0.16	-0.26	-0.49	-0.78
Debt / FCF Ratio	-8.72	2.44	-0.32	-0.69	-0.30	-1.11
Quick Ratio	2.67	2.75	3.48	3.60	7.26	2.15
Current Ratio	4.22	3.98	5.85	5.71	11.44	3.42
Asset Turnover	1.26	1.29	0.76	0.57	0.50	0.91
Interest Coverage	-718.00	-786.50	-368.10	-99.17	-42.33	-17.69
Return on Equity (ROE)	-17.00%	-18.20%	-94.40%	-33.90%	-46.80%	-92.50%
Return on Assets (ROA)	-12.90%	-14.30%	-55.90%	-23.00%	-27.80%	-30.20%
Return on Capital (ROIC)	-15.04%	-15.63%	-64.85%	-25.62%	-30.65%	-45.86%
Earnings Yield	-6.46%	-4.34%	-61.83%	-6.80%	-5.63%	-4.32%
FCF Yield	-0.88%	2.07%	-28.24%	-2.41%	-8.44%	-2.89%
Buyback Yield / Dilution	-1.98%	-0.86%	-2.79%	-10.35%	-20.37%	-10.16%
Total Shareholder Return	-1.98%	-0.86%	-2.79%	-10.35%	-20.37%	-10.16%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).